Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
IVX-037 by ImmVirX for Metastatic Ovarian Cancer: Likelihood of Approval
IVX-037 is under clinical development by ImmVirX and currently in Phase I for Metastatic Ovarian Cancer. According to GlobalData, Phase...
IVX-037 by ImmVirX for Metastatic Colorectal Cancer: Likelihood of Approval
IVX-037 is under clinical development by ImmVirX and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData, Phase...
IVX-037 by ImmVirX for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
IVX-037 is under clinical development by ImmVirX and currently in Phase I for Adenocarcinoma Of The Gastroesophageal Junction. According to...
IVX-037 by ImmVirX for Solid Tumor: Likelihood of Approval
IVX-037 is under clinical development by ImmVirX and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
IVX-037 by ImmVirX for Gastric Cancer: Likelihood of Approval
IVX-037 is under clinical development by ImmVirX and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I...